Cancer Research Cancer Epigenetics  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holland, J. D.
Right arrow Articles by McColl, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holland, J. D.
Right arrow Articles by McColl, S. R.
[Cancer Research 66, 4117-4124, April 15, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Differential Functional Activation of Chemokine Receptor CXCR4 Is Mediated by G Proteins in Breast Cancer Cells

Jane D. Holland1, Marina Kochetkova1, Chareeporn Akekawatchai1, Mara Dottore2, Angel Lopez2 and Shaun R. McColl1

1 School of Molecular and Biomedical Science, the University of Adelaide and 2 Cytokine Receptor Laboratory, Institute of Medical and Veterinary Science, Adelaide, Australia

Requests for reprints: Shaun McColl, Chemokine Biology, School of Molecular and Biomedical Science, the University of Adelaide, Adelaide, South Australia 5005, Australia. Phone: 618-8303-4259; Fax: 618-8303-3337; E-mail: shaun.mccoll{at}adelaide.edu.au.

CXCR4 is a G protein–coupled receptor of considerable biological significance, and among its numerous functions, it is suggested to play a critical role in cancer metastasis. We have investigated the expression and function of CXCR4 in a range of breast cancer cell lines covering a spectrum of invasive phenotypes and found that, while surface levels of CXCR4 were uniform across the entire panel, only highly invasive cells that are metastatic in immunocompromised mice expressed functional receptors. CXCL12/SDF-1 induced cellular responses such as calcium mobilization, actin polymerization, and chemotaxis in metastatic cells, whereas noninvasive cells were unresponsive. Moreover, CXCL12 activated multiple signaling pathways downstream of G proteins in highly invasive cells but failed to activate any of the examined kinase cascades in noninvasive cell lines. This blockade in nonmetastatic cell lines seems to be due to the inability of G protein {alpha} and ß subunits to form a heterotrimeric complex with CXCR4. G{alpha} and Gß were able to bind to CXCR4 independently in all cell lines, but the association of G protein {alpha}ß{gamma} heterotrimers with the receptor, a prerequisite for signal transduction downstream from G protein–coupled receptors, was only observed in the highly invasive cell lines. Our findings show, for the first time, that CXCR4 function is subject to complex and potentially tightly controlled regulation in breast cancer cells via differential G protein–receptor complex formation, and this regulation may play a role in the transition from nonmetastatic to malignant tumors. (Cancer Res 2006; 66(8): 4117-24)




This article has been cited by other articles:


Home page
Cancer Res.Home page
Y. Xie, D. W. Wolff, T. Wei, B. Wang, C. Deng, J. K. Kirui, H. Jiang, J. Qin, P. W. Abel, and Y. Tu
Breast Cancer Migration and Invasion Depend on Proteasome Degradation of Regulator of G-Protein Signaling 4
Cancer Res., July 15, 2009; 69(14): 5743 - 5751.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Wong and W. Korz
Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside
Clin. Cancer Res., December 15, 2008; 14(24): 7975 - 7980.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Marlow, P. Strickland, J. S. Lee, X. Wu, M. PeBenito, M. Binnewies, E. K. Le, A. Moran, H. Macias, R. D. Cardiff, et al.
SLITs Suppress Tumor Growth In vivo by Silencing Sdf1/Cxcr4 within Breast Epithelium
Cancer Res., October 1, 2008; 68(19): 7819 - 7827.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
A Vincent-Salomon, F C Bidard, and J Y Pierga
Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues
J. Clin. Pathol., May 1, 2008; 61(5): 570 - 576.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. Sutton, V. Friand, S. Brule-Donneger, T. Chaigneau, M. Ziol, O. Sainte-Catherine, A. Poire, L. Saffar, M. Kraemer, J. Vassy, et al.
Stromal Cell-Derived Factor-1/Chemokine (C-X-C Motif) Ligand 12 Stimulates Human Hepatoma Cell Growth, Migration, and Invasion
Mol. Cancer Res., January 1, 2007; 5(1): 21 - 33.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Meijer, I. S. Zeelenberg, B. Sipos, and E. Roos
The CXCR5 Chemokine Receptor Is Expressed by Carcinoma Cells and Promotes Growth of Colon Carcinoma in the Liver
Cancer Res., October 1, 2006; 66(19): 9576 - 9582.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.